KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Other Accumulated Expenses (2016 - 2026)

Chemed filings provide 18 years of Other Accumulated Expenses readings, the most recent being $60.8 million for Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses fell 7.5% year-over-year to $60.8 million, compared with a TTM value of $60.8 million through Mar 2026, down 7.5%, and an annual FY2025 reading of $62.1 million, up 9.44% over the prior year.
  • Other Accumulated Expenses hit $60.8 million in Q1 2026 for Chemed, down from $62.1 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $69.3 million in Q1 2023, with the low at $640000.0 in Q2 2024.
  • Median Other Accumulated Expenses over the past 5 years was $55.3 million (2023), compared with a mean of $41.7 million.
  • The sharpest move saw Other Accumulated Expenses plummeted 97.74% in 2022, then surged 8375.96% in 2023.
  • Year by year, Other Accumulated Expenses stood at $4.5 million in 2022, then soared by 1147.17% to $55.6 million in 2023, then grew by 2.03% to $56.7 million in 2024, then rose by 9.44% to $62.1 million in 2025, then fell by 2.0% to $60.8 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $60.8 million, $62.1 million, and $65.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.